Biotechnology Research
New York, New York
2-10 employees
Founded Sep 2022
About Nephrogen
Nephrogen is a biotechnology company dedicated to creating curative genomic medicines for kidney and pancreatic diseases. Leveraging its proprietary NeFIND™ AI platform, the company engineers highly efficient and less immunogenic gene delivery vectors to develop novel therapies. Its primary focus is on treating the underlying genetic causes of conditions like polycystic kidney disease (PKD) to improve patient longevity and quality of life.
Company Classification
Customer Types
B2BB2B2C
Business Models
ProductsLicensing
Product & Service Types
Gene delivery vector engineering platformGenomic medicines for kidney disease
Funding
No. of Funding Rounds
1
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos